Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Monashee Investment Management
AddedFeb 13, 2024
UpdatedJun 28, 2026
Monashee Investment Management

Monashee Investment Management

Operating

Monashee Investment Management LLC: A Boston-based hedge fund management company.

Location
Boston, MA, US
Founded
2012
Firm
Compare
Portfolio
Employees
Website

Monashee Investment Management LLC is a Boston-based hedge fund management company that focuses on later-stage investments, primarily participating in Series B, Series C, and post-IPO equity rounds. The firm typically invests in high-growth sectors such as biotechnology, therapeutics, and advanced technologies, with investment sizes ranging from $55 million to $250 million.

Notable portfolio companies include Astranis, Caribou Biosciences, and Turntide Technologies. Monashee's key partners and decision-makers leverage their extensive industry experience to provide strategic guidance and support to portfolio companies. The firm is known for its robust investment philosophy centered around identifying transformative technologies and innovative healthcare solutions. Monashee also offers unique value-add services such as operational expertise and network access to help portfolio companies scale effectively.

Monashee Investment Management - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments16
Current Portfolio Count16
Total Portfolio Exits0

Top Investment Stages

Series C7 (46.7%)
Post Ipo Equity3 (20.0%)
Series B3 (20.0%)
Convertible Note1 (6.7%)
Series A1 (6.7%)

Stage Mix

Series C 47%Post Ipo Equity 20%Series B 20%Convertible Note 7%Series A 7%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Scipher Medicine logo

Scipher Medicine

Korro Bio logo

Korro Bio

HotSpot Therapeutics logo

HotSpot Therapeutics

Better Therapeutics logo

Better Therapeutics

Skyryse logo

Skyryse

Garuda Therapeutics logo

Garuda Therapeutics

Strata Oncology logo

Strata Oncology

Turntide Technologies logo

Turntide Technologies

Kindbody logo

Kindbody

Ribon Therapeutics logo

Ribon Therapeutics

HiberCell logo

HiberCell

Astranis logo

Astranis

X4 Pharmaceuticals logo

X4 Pharmaceuticals

Caribou Biosciences logo

Caribou Biosciences

eGenesis logo

eGenesis

Fulcrum Therapeutics logo

Fulcrum Therapeutics

Similar Investment Firms

monashees logo

monashees

monashees.com

Monashee Capital logo

Monashee Capital

Montrose Capital Partners logo

Montrose Capital Partners

Monet Capital logo

Monet Capital

monetcapital.com

Fairmount Funds Management logo

Fairmount Funds Management

fairmountfunds.com

Meson Capital Partners logo

Meson Capital Partners

mesoncapital.com

MonCap logo

MonCap

moncap.vc

Meyer Global Management logo

Meyer Global Management

Montlake Capital logo

Montlake Capital

Morgan Stanley Investment Management logo

Morgan Stanley Investment Management

morganstanley.com

Montreux Equity Partners logo

Montreux Equity Partners

mepvc.com

MPM Capital logo

MPM Capital

mpmbioimpact.com

Plaisance Capital Management logo

Plaisance Capital Management

plaisancecap.com

MP Healthcare Venture Management logo

MP Healthcare Venture Management

mp-healthcare.com

McKinley Capital Management logo

McKinley Capital Management

Monashee Investment Management - Classification

Also Known As
  • Monashee Investment Management LLC
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end
Show 5 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
SIC
  • 6000Depository Institutions
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified